Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May 14;39(19):1687-1697.
doi: 10.1093/eurheartj/ehx037.

Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative

Alexandra J Lansky  1   2   3 , Steven R Messé  4 , Adam M Brickman  5 , Michael Dwyer  6 , H Bart van der Worp  7 , Ronald M Lazar  5 , Cody G Pietras  1   2 , Kevin J Abrams  8 , Eugene McFadden  9 , Nils H Petersen  10 , Jeffrey Browndyke  11 , Bernard Prendergast  12 , Vivian G Ng  1   2 , Donald E Cutlip  13 , Samir Kapadia  14 , Mitchell W Krucoff  15 , Axel Linke  16 , Claudia Scala Moy  17 , Joachim Schofer  18 , Gerrit-Anne van Es  19 , Renu Virmani  20 , Jeffrey Popma  21 , Michael K Parides  21 , Susheel Kodali  22 , Michel Bilello  23 , Robert Zivadinov  6 , Joseph Akar  1 , Karen L Furie  24 , Daryl Gress  25 , Szilard Voros  26 , Jeffrey Moses  22 , David Greer  10 , John K Forrest  1 , David Holmes  27 , Arie P Kappetein  28 , Michael Mack  29 , Andreas Baumbach  3
Affiliations

Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative

Alexandra J Lansky et al. Eur Heart J. .

Abstract

Surgical and catheter-based cardiovascular procedures and adjunctive pharmacology have an inherent risk of neurological complications. The current diversity of neurological endpoint definitions and ascertainment methods in clinical trials has led to uncertainties in the neurological risk attributable to cardiovascular procedures and inconsistent evaluation of therapies intended to prevent or mitigate neurological injury. Benefit-risk assessment of such procedures should be on the basis of an evaluation of well-defined neurological outcomes that are ascertained with consistent methods and capture the full spectrum of neurovascular injury and its clinical effect. The Neurologic Academic Research Consortium is an international collaboration intended to establish consensus on the definition, classification, and assessment of neurological endpoints applicable to clinical trials of a broad range of cardiovascular interventions. Systematic application of the proposed definitions and assessments will improve our ability to evaluate the risks of cardiovascular procedures and the safety and effectiveness of preventive therapies.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Imaging-Driven Diagnosis of Stroke and CNS Infarction (for Studies With Routine Neuroimaging). Assessment of the consistency of signs and symptoms with lesion distribution is a matter of clinical judgment and, in clinical trials, should be adjudicated by an independent Clinical Events Committee. CNS, central nervous system; DW, diffusion-weighted; MRI, magnetic resonance imaging; TIA, transient ischemic attack.
Figure 2
Figure 2
Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: Recommended Timing of Clinical and Imaging Evaluations. This figure provides recommended and optional assessments for each time point; appropriate follow-up duration will vary with device/procedure type and the goals of the study. *Cognitive screening (e.g., Montreal Cognitive Assessment) is recommended for all trial categories. Comprehensive cognitive assessment is recommended for studies with neurological outcomes as efficacy endpoints (Categories II and III in Table 2), and optional for safety studies (Category I in Table 2). MRI = magnetic resonance imaging.
See this image and copyright information in PMC

References

    1. Eggebrecht H, Schmermund A, Voigtlander T, et al.Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention 2012;8:129–38. - PubMed
    1. Filsoufi F, Rahmanian PB, Castillo JG, et al.Incidence, imaging analysis, and early and late outcomes of stroke after cardiac valve operation. Am J Cardiol 2008;101:1472–8. - PubMed
    1. Puskas JD, Winston AD, Wright CE, et al.Stroke after coronary artery operation: incidence, correlates, outcome, and cost. Ann Thorac Surg 2000;69:1053–6. - PubMed
    1. Kapadia S, Agarwal S, Miller DC, et al.Insights into timing, risk factors, and outcomes of stroke and transient ischemic attack after transcatheter aortic valve replacement in the PARTNER Trial (Placement of Aortic Transcatheter Valves). Circ Cardiovasc Interv 2016;9:e002981. - PubMed
    1. Kleiman NS, Maini BJ, Reardon MJ, et al.Neurological events following transcatheter aortic valve replacement and their predictors: a report from the CoreValve Trials. Circ Cardiovasc Interv 2016;9:e003551. - PubMed

Publication types

MeSH terms